Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 2, 2009, Pages

  Song, Dae Jin ^a,b   Min, Myung Goo ^a   Miller, Marina ^a   Cho, Jae Youn ^a   Broide, David H ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Korea University College of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergy; Eosinophils

Indexed keywords

ALLERGEN; CORTICOSTEROID; OVALBUMIN; TOBACCO SMOKE; TRANSFORMING GROWTH FACTOR BETA1;

AIRWAY HYPERREACTIVITY; AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; LUNG FIBROSIS; LUNG FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; TRACHEA MUSCLE;

ADRENAL CORTEX HORMONES; ALLERGENS; ANIMALS; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; FIBROSIS; MICE; MICE, INBRED BALB C; MUCUS; MUSCLE, SMOOTH; OVALBUMIN; PNEUMONIA; TOBACCO SMOKE POLLUTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67651202219     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90588.2008     Document Type: Article

References (35)

1. Alcorn J, Rinaldi L, Jaffe E, van Loon M, Bates J, Janssen-Heininger Y, Irvin C. Transforming growth factor-β1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 176: 974-982, 2007.
2. Booij-Noord N, Orie NGM, deVaries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 48: 344-354, 1971.
3. Bouzigon E, Corda E, Aschard H, Dizier MH, Boland A, Bousquet J, Chateigner N, Gormand F, Just J, Le Moual N, Scheinmann P, Siroux V, Vervloet D, Zelenika D, Pin I, Kauffmann F, Lathrop M, Demenais F. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 359: 1985-1994, 2008.
4. Chalmer GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 57: 226-230, 2002.
5. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 168: 1308-1311, 2003.
6. Chilmonczyk BA, Salmun LM, Megathlin KN, Neveux LM, Palomaki GE, Knight GJ, Pulkkinen AJ, Haddow JE. Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med 328: 1665-1669, 1993.
7. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Friedman S, Broide DH. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 113: 551-560, 2004.
8. Cho JY, Miller M, McElwain K, McElwain S, Broide DH. Combination of corticosteroid therapy and allergen avoidance reverses allergen-induced airway remodeling in mice. J Allergy Clin Immunol 116: 1116-1122, 2005.
9. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145: 669-674, 1992.
10. Eisner MD, Klein J, Hammond SK, Koren G, Lactao G, Iribarren C. Directly measured second hand smoke exposure and asthma health outcomes. Thorax 60: 814-821, 2005.
11. Eisner MD, Yelin EH, Henke J, Shiboski SC, Blanc PD. Environmental tobacco smoke and adult asthma. The impact of changing exposure status on health outcomes. Am J Respir Crit Care Med 158: 170-175, 1998.
12. Fattouh R, Midence G, Arias K, Johnson J, Walker T, Goncharova S, Souza K, Gregory R, Lonning S, Gauldie J, Jordana M. Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 177: 593-603, 2008.
13. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wango A, Ludwig MS, Barnes N, Robinson D, Kay AB. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112: 1029-1036, 2003.
14. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, Sovijarvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA. Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325: 388-392, 1991.
15. Kumar R, Curtis LM, Khiani S, Moy J, Shalowitz MU, Sharp L, Durazo-Arvizu RA, Shannon JJ, Weiss KB. A community-based study of tobacco smoke exposure among inner-city children with asthma in Chicago. J Allergy Clin Immunol 122: 754-759, 2008.
16. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 339: 1194-1200, 1998.
17. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, Deykin A, DiMango E, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lernanske RF, Leone FT, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Wechsler ME, Fahy JV; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 175: 783-790, 2007.
18. Le AV, Cho JY, Miller M, McElwain S, Golgotiu K, Broide DH. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J Immunol 178: 7310-7316, 2007.
19. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776, 2004.
20. Lim DH, Cho JY, Song DJ, Lee SY, Miller M, Broide DH. PI3Kγ-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol 296: L210-L219, 2009.
21. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 174: 5774-5780, 2005.
22. Menon P, Rando RJ, Stankus RP, Salvaggio JE, Lehrer SB. Passive cigarette smoke-challenge studies: increase in bronchial hyperreactivity. J Allergy Clin Immunol 89: 560-566, 1992.
23. Miller M, Cho JY, McElwain K, McElwain S, Shim JY, Manni M, Baek JS, Broide DH. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am J Physiol Lung Cell Mol Physiol 290: L162-L169, 2006.
24. Min MG, Song DJ, Miller M, McElwain S, Ferguson P, Broide DH. Coexposure to environmental tobacco smoke increases levels of allergeninduced airway remodeling in mice. J Immunol 178: 5321-5328, 2007.
25. O'Bryne PM, Pedersen S, Busse WW, Tan W, Chen YZ, Ohlsson SV, Ulllman A, Lamm CJ, Pauwels RA. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 129: 1478-1485, 2006.
26. O'Byrne PM, Gauvreau GM, Brannan JD. Provoked models of asthma: what have we learnt? Clin Exp Allergy 39: 181-192, 2009.
27. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 336: 1405-1411, 1997.
28. Rumold R, Jyrala M, Diaz-Sanchez DD. Second hand smoke induces allergic sensitization in mice. J Immunol 167: 4765-4770, 2001.
29. Seymour BW, Pinkerton KE, Friebertshauser KE, Coffman RL, Gershwin LJ. Second hand smoke is an adjuvant for Th2 responses in a murine model of allergy. J Immunol 159: 6169-6175, 1997.
30. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo CA. Cigarette smoking among asthmatic adults present to 64 emergency departments. Chest 123: 1472-1479, 2003.
31. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159: 1043-1051, 1999.
32. Stankus RP, Menon PK, Rando RJ, Glindmeyer H, Salvaggio JE, Lehrer SB. Cigarette smoke-sensitive asthma: challenge studies. J Allergy Clin Immunol 82: 331-338, 1988.
33. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343: 332-336, 2000.
34. Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 5: 57-63, 2005.
35. Tomlinson JEM, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 60: 282-287, 2005.